A Open Label, Post Marketing Surveillance Study Following Transfusion of INTERCEPT Platelet Components

Clinical trial NCT02549222 · COMPLETED

Trial details

NCT number: NCT02549222
Sponsor: Cerus Corporation
Status: COMPLETED
Study type: OBSERVATIONAL

Transfusion Related Acute Lung Injury

Start date: 2015-12-01
Primary completion: 2020-09-01
Enrollment: 2291

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.